| ICEVX | VTISX | ICEVX / VTISX | |
| Total Expense Ratio | 1.23 | 0.05 | 2,617% |
| Annual Report Gross Expense Ratio | 1.23 | 0.05 | 2,617% |
| Fund Existence | 19 years | 9 years | - |
| Gain YTD | 27.418 | 28.929 | 95% |
| Front Load | 6% | N/A | - |
| Min. Initial Investment | 15000 | 3000000000 | 0% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 267M | 554B | 0% |
| Annual Yield % from dividends | 1.10 | 2.75 | 40% |
| Returns for 1 year | 23.46 | 25.12 | 93% |
| Returns for 3 years | 44.35 | 49.36 | 90% |
| Returns for 5 years | 35.61 | 39.69 | 90% |
| Returns for 10 years | 69.03 | N/A | - |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| AIVFX | 20.82 | 0.19 | +0.92% |
| American Funds International Vntg F-2 | |||
| GAGCX | 36.40 | 0.23 | +0.64% |
| Gabelli Global Rising Income and Div AAA | |||
| BRSSX | 15.14 | 0.04 | +0.26% |
| MFS Blended Research Small Cap Eq R2 | |||
| PAWAX | 81.79 | 0.12 | +0.15% |
| T. Rowe Price All-Cap Opportunities-Adv | |||
| AVUSX | 21.26 | 0.02 | +0.09% |
| Avantis® U.S. Equity Institutional | |||